Brief: Mangoceuticals Granted 180-Day Extension To Meet Nasdaq Minimum Bid Price Requirement
02/05/2024 13:13
May 2 (Reuters) - Mangoceuticals Inc MGRX.O :
* MANGOCEUTICALS GRANTED 180-DAY EXTENSION TO MEET NASDAQ
MINIMUM
BID PRICE REQUIREMENT AND CONDITIONAL APPROVAL OF COMPLIANCE
WITH NASDAQ’S MINIMUM STOCKHOLDERS’ EQUITY REQUIREMENT
Source text for Eikon: ID:nGNX7cr7jF
Further company coverage: MGRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Mangoceuticals
See all newsBrief: Mangoceuticals And Nuclea Energy Terminate Business Combination Agreement On August 19
Brief: Mangoceuticals Inc.’S Merger Partner, Nuclea Energy, Inc., Enters Into Definitive Agreement To Acquire Moltex Energy’S Advanced Nuclear Technology Assets
NASDAQ RESUMED AT 10:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:30 AM
NASDAQ RESUMED AT 10:27 AM